Ophthalmic-focused artificial intelligence dev Pr3vent said yesterday that it closed an undisclosed Series A round of financing to support its machine-vision based system intended for detecting eye disease in newborns. The round was led by InFocus Capital Partners, the Palo Alto, Calif.-based company said, and follows a successful seed round last October jointly led by […]